LARGO, Fla., Sept. 2, 2008 (GLOBE NEWSWIRE) -- GeoPharma, Inc.
(Nasdaq:GORX) (the "Company") announced today that it will release
earnings for the second quarter of fiscal year...
LARGO, Fla., Feb. 14 /PRNewswire-FirstCall/ -- GeoPharma, Inc.
(Nasdaq: GORX) announced record revenues of $18.2 million for the third
quarter representing more...
LARGO, Fla., Feb. 6 /PRNewswire-FirstCall/ -- GeoPharma, Inc.
(Nasdaq: GORX) (the 'Company') announced today in an effort to communicate its
story to as wide of...
CEOs of Participating Companies Will Deliver Presentations Feb. 7, 2008 At the Four Seasons Resort in Scottsdale, Ariz.
ORLANDO, Fla., Dec. 10, 2007 (PRIME NEWSWIRE) -- RedChip Visibility,...
LARGO, Fla., Dec. 3 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the 'Company') announced today that it has signed an agreement with the University of South Florida Research...
LARGO, Fla., Nov. 19 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the 'Company') GeoPharma, Inc. reached an agreement with Vetoquinol USA (http://www.vetoquinolusa.com/index1.html) for...
LARGO, Fla., Nov. 12 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the 'Company') GeoPharma, Inc. announced today it has received an approval from the FDA to begin producing Carprofen....
$100 Million in Combined Company Projected Revenues Annually
GeoPharma, Inc.
(Nasdaq: GORX Stocks Drug) (the 'Company') today announced the execution of an agreement
to acquire...